Last reviewed · How we verify

NCT05983653

Evaluation of Arthrocentesis With and Without PRP Injection in Patients With Disc Displacement With Reduction.

Completed NA Last updated 27 August 2024
What this trial tests

NA trial testing arthrocentesis without PRP in TMJ Disc Disorder in 74 participants. Completed in 1 April 2024.

Timeline
1 August 2023
Primary endpoint
1 March 2024
1 April 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment74
Start date1 August 2023
Primary completion1 March 2024
Estimated completion1 April 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 15 to 70, any sex, with TMJ Disc Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aiming To evaluate the treatment effect (anti-inflammatory and healing ) of PRP with arthrocentesis versus arthrocentesis alone on the management of anterior disc displacement with reduction

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05983653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing